Well Lead Medical Co (SHSE:603309) Interest Expense: ¥-17 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603309 Well Lead Medical Co Ltd SHSE:603309
85 GF Score
Price ¥11.99
GF Value ¥14.45
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Well Lead Medical Co Interest Expense?

Well Lead Medical Co SHSE:603309 +1.27% 85 Interest Expense is ¥-17 Mil as of Jun. 2026. GuruFocus rates SHSE:603309 with a GF Score™ of 85/100 and a GF Value™ of ¥14.45 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Well Lead Medical Co's interest expense for the three months ended in Jun. 2026 was ¥ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥-17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Well Lead Medical Co's Operating Income for the three months ended in Jun. 2026 was ¥ 66 Mil. Well Lead Medical Co's Interest Expense for the three months ended in Jun. 2026 was ¥ -5 Mil. Well Lead Medical Co's Interest Coverage for the quarter that ended in Jun. 2026 was 12.46. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Well Lead Medical Co  (SHSE:603309) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Well Lead Medical Co's Interest Expense for the three months ended in Jun. 2026 was ¥-5 Mil. Its Operating Income for the three months ended in Jun. 2026 was ¥66 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was ¥389 Mil.

Well Lead Medical Co's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*66.347/-5.323
=12.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Well Lead Medical Co Interest Expense Historical Data

* Premium members only.

The historical data trend for Well Lead Medical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Well Lead Medical Co Interest Expense Chart

Well Lead Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.49 -7.87 -9.12 -12.32 -18.19

Well Lead Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.48 -1.09 -7.28 -3.47 -5.32
SHSE:603309
85GF Score
Well Lead Medical Co Ltd SHSE:603309
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Well Lead Medical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ¥-17 Mil mean?
Well Lead Medical Co (SHSE:603309) has a Interest Expense of ¥-17 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Well Lead Medical Co and its competitors.
Is Well Lead Medical Co's Interest Expense too high?
Well Lead Medical Co's current Interest Expense is ¥-17 Mil. Overall, Well Lead Medical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Well Lead Medical Co's Interest Expense compare to ISRG and BDX?
Well Lead Medical Co's Interest Expense of ¥-17 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Well Lead Medical Co and its competitors. Well Lead Medical Co's current Interest Expense is ¥-17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Well Lead Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Well Lead Medical Co (SHSE:603309) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.45, compared to a current price of ¥11.99 — trading 17% below its estimated fair value. The current Interest Expense is ¥-17 Mil. Well Lead Medical Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Well Lead Medical Co (SHSE:603309), the current Interest Expense is ¥-17 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?

Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued. The current stock price of ¥11.99 is trading 17% below its estimated GF Value™ of ¥14.45. GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603309:

  • Interest Expense: ¥-17 Mil
  • GF Value™: ¥14.45 vs. price of ¥11.99 (17% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Well Lead Medical Co Business Description

Address No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
85GF Score

Get the complete analysis for SHSE:603309

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.99
Price
¥14.45
GF Value